Grant4

Silvaco Group, Inc.

Total Value

Filing Date

Sep 1, 2026

1 transaction

Trade Summary

On Aug 29, 2026, RHINES WALDEN C, Chief Executive Officer, Director, reported $0 of Silvaco Group, Inc. (SVCO) across 1 transaction. The filing covers Common Stock and reflects balanced net activity of $0. Insider transactions are sourced from SEC Form 4 disclosures and should be reviewed alongside company fundamentals and the insider's broader trading history.

Insider Information

Name: RHINES WALDEN C
Role: Chief Executive Officer, Director
Location: SANTA CLARA, CA

Filing Details

Filing Date: Sep 1, 2026
Transaction Date: Aug 29, 2026
Accession Number: 0001628280-26-059949
Form Type: 4

Non-Derivative Transactions

Date	Security	Shares	Price	Type	Value
Aug 29, 2026	Common Stock	250,376	—	Grant/Award	—

Want live alerts when RHINES WALDEN C trades again?

Download Insider Trades to track SVCO, follow insiders, and get mobile alerts when new SEC Form 4 filings are published.

iOS App Android App

Footnotes

(F1)Represents Restricted Stock Units ("RSUs") granted to the Reporting Person pursuant to that certain Employment Agreement, effective as of August 19, 2025 (the "Agreement"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted on August 29, 2026, and will vest on March 31, 2027, provided that the vesting of the RSUs shall be accelerated in the event the Issuer terminates the Reporting Person's employment for any reason or the Reporting Person terminates his employment following a material breach of the Agreement by the Issuer which is not cured within 30 days after the Reporting Person provides written notice, in each case, prior to March 31, 2027.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RHINES WALDEN C

(Last)

(First)

(Middle)

C/O SILVACO GROUP, INC.

4701 PATRICK HENRY DRIVE, BUILDING #23

(Street)

SANTA CLARA

95054

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Silvaco Group, Inc. [ SVCO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/29/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/29/2026		A		250,376⁽¹⁾	A	$0	539,209	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Represents Restricted Stock Units ("RSUs") granted to the Reporting Person pursuant to that certain Employment Agreement, effective as of August 19, 2025 (the "Agreement"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs were granted on August 29, 2026, and will vest on March 31, 2027, provided that the vesting of the RSUs shall be accelerated in the event the Issuer terminates the Reporting Person's employment for any reason or the Reporting Person terminates his employment following a material breach of the Agreement by the Issuer which is not cured within 30 days after the Reporting Person provides written notice, in each case, prior to March 31, 2027.

Remarks:

	/s/ Candace Jackson, as Attorney-in-Fact	09/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Form 4 as rendered by the SEC from accession 0001628280-26-059949.

Silvaco Group, Inc.

Trade Summary

Company Information

Insider Information

Filing Details

Non-Derivative Transactions

Want live alerts when RHINES WALDEN C trades again?

Footnotes

SEC Form 4

SEC Filing

SEC Form 4